Cancer Genomics An introduction - Week 10 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Statistics

A

Cancer is the second leading cause of death in the world
Testicular cancer – 98% of patients survive 10 years or more
Pancreatic cancer – only 1% of patients survive 10 years or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Cancer

A

Uncontrollable cell division where the abnormally dividing cells eventually spread to or invade other tissues – metastasis which could lead to the death of a patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cell division - mitosis

A

Cell reproduce by cell division (mitosis)

1 cell becomes 2, 2 cells become 4, 4 cells become 8 etc
• Mechanism for making new body cell and is distinct from meiosis (making egg and sperm cells – not covered in this module)
• The cell cycle is the whole series of changes the cell goes through from the time it is first formed until it divides into two daughter cells starting and ending with mitosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In normal healthy tissue the progression through cell division/ cell cycle is

A

tightly regulated and only occurs when needed stimulated by cell signalling pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cancer Terminology

A

Cancer or neoplasia (neo – new, plasia – tissue/cell) or malignant tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tumour

A

swelling or mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

tumour in the context of cancer

A

referring to a mass of non structured new cells with no known purpose in the physiological function of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Benign - differentiation

A

Well differentiated, structure similar to tissue of origin (more likely to retain some of the function of their cell of origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Benign - rate of growth

A

Slow growing and may halt or regress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benign - local invasion

A

Usually cohesive and well defined (capsular), does not invade or infiltrate into other tissues (relatively innocent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benign - metastasis

A

Absent (do not spread to other sites in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Malignant - differentiation

A

Poorly differentiated (or completely undifferentiated or anaplastic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Malignant - rate of growth

A

Erratic but can be fast (faster than benign)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Malignant - local invasion

A

Locally invasive and infiltrates surrounding tissue (invade and destroy adjacent structures and spread/metastasise to different sites in the body)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Malignant - metastasis

A

Frequent but more likely with large undifferentiated tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

• Benign tumours

A

In general have the suffix OMA attached to the name of the cell type the tumour originates
 Fibroma (fibrous tissue benign neoplasm)
 Adenoma (Epithelial benign neoplasm)

17
Q

Malignant tumours

A

Similar nomenclature as benign tumours (with additions)
 Fibrosarcoma
 Adenocarcinoma

18
Q

Liver =

A

Hepatic adenoma (benign) or hepatocellular carcinoma (malignant)

19
Q

Metastasis

A

(characteristic that differentiates benign and malignant tumours)
• Spread of a tumour to sites that are physically discontinuous from the primary tumour. Metastatic spread of a tumour decreases the possibility of a cure so understanding metastatic spread is critical especially when approximately 30% of newly diagnosed solid tumours present with metastases.

20
Q

Depending on how lymph and blood travel through the body Primary tumours often have a preferred site of metastasis

A

in addition to the lymph nodes i.e. tumours of bladder, breast, colon and ovary
From these examples you can see that bone, liver and lung are common sites of metastasis

21
Q

Three main pathways that a tumour can spread to distant sites

A

Seeding of body cavities and surfaces (can occur when a malignant tumour penetrates into an open field such as the peritoneal cavity in ovarian cancer, spread through

Lymphatic spread of cancer cells (spread through the lymphatic system is the most common pathway for the initial dissemination of carcinomas while tumours do not contain functional lymphatic vessels, it appears that the vessels at the edges of tumours are sufficient for lymphatic spread.)

Hematogenous spread (blood vessels) (tumours can also spread through nearby blood vessels either through veins (more common) and arteries (less common as arteries are thicker, more muscular and harder for tumour cells to penetrate)

22
Q

Metastasis are a multiple step process and involve

A

growing into or invading nearby tissue, moving through the walls of nearby lymph or blood vessels, travelling through the lymphatic/blood stream to other parts of the body. Stopping in small blood vessels at a distant location then managing to invade these blood vessels and moving into surrounding tissue, ultimately growing into a tiny tumour which develops blood vessels which will allow it to keep growing to a larger size.

23
Q

To undergo these metastatic step processes,

A

tumour cells have to acquire a number of different characteristics. Similarly normal cell to become a tumour cell initially the normal cell needs to acquire a number of different characteristics

24
Q

Collectively these characteristics are defined as the

A

“hallmarks of cancer” and were first defined by Hanahan and Weinberg in 2000

25
Q

To help inform treatment decisions and inform patients of their prognosis, cancers are examined to determine

A

stage and grade:

26
Q

grade

A

histological assessment of state of differentiation

27
Q

differentiation of low grade tumours

A

generally well differentiated

28
Q

differentiation of high grade tumours

A

poorly differentiated or completely undifferentiated

29
Q

Grade X

A

Grade isn’t known

30
Q

Grade 1

A

Well differentiated, low grade

31
Q

Grade 2

A

Moderately differentiated, intermediate grade

32
Q

Grade 3:

A

Poorly differentiated, high grade

33
Q

Grade 4:

A

Undifferentiated, high grade

34
Q

Grading used for most tumours except for some exceptions i.e.

A

o Gleason score for prostate cancer

o Nottingham score for prostate cancer

35
Q

Stage

A

looking at the size and spread of the tumour

36
Q

Solid tumours TNM system (most common system)

A

 T = Primary tumour (size, invasive depth and infiltration)
 N = Involvement of the lymph nodes (number of lymph nodes)
 M = Distant metastases (have distant metastases been observed)

37
Q

Each tumour type has its own and often complex staging system based on these principles but there are 2 main systems :

A

 Union of Internal Cancer Control (UICC)
• Aims to be more succinct, meets the needs of the worldwide community and used in the UK
 American Joint Committee on Cancer (AJCC)
• Aims to be comprehensive and meet the needs of US academics
 Both systems are very similar